Serum Calprotectin Is Not Predictive for Successful Dose Reduction or Discontinuation of TNF Inhibitors in RA Patients with Low Disease Activity

被引：0
|
作者：
den Broeder, Nathan [1 ]
Tweehuysen, Lieke [1 ]
van Herwaarden, Noortje [1 ]
Vogl, Thomas [2 ]
van den Hoogen, F. H. J. [1 ]
Thurlings, Rogier [3 ]
Den Broeder, Alfons A. [1 ]
机构：
[1] Sint Maartensklin, Rheumatol, Nijmegen, Netherlands
[2] Univ Munster, Munster, Germany
[3] Radboudumc, Rheumatol, Nijmegen, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
421
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SERUM CALPROTECTIN IS NOT PREDICTIVE FOR SUCCESSFUL DOSE REDUCTION OR DISCONTINUATION OF TNF INHIBITORS IN RA PATIENTS WITH LOW DISEASE ACTIVITY
    Den Broeder, N.
    Tweehuysen, L.
    Vogl, T.
    van Herwaarden, N.
    van den Hoogen, F. H. J.
    Thurlings, R. M.
    den Broeder, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 526 - 526
  • [2] Disease activity-guided TNF inhibitor dose reduction was noninferior to continuing TNF inhibitors for RA flares
    Ramirez-Lafita, Francisco
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [3] DISEASE ACTIVITY MEASURES AND OTHER POTENTIAL PREDICTORS OF SUCCESSFUL TNF INHIBITORS TAPERING IN RA PATIENTS
    Bogas, P.
    Plasencia, C.
    Guinazu, F.
    Novella-Navarro, M.
    Navarro-Compan, V.
    Franco Gomez, K. N.
    Monjo, I.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 616 - 617
  • [4] Calprotectin Serum Levels Strongly Predict Disease Flare in RA and Psa Patients with Low Disease Activity Treated with TNF Inhibitors. a One-Year Prospective Cohort Study
    Inciarte-Mundo, Jose
    Victoria Hernandez, M.
    Ruiz-Esquide, Virginia
    Cabrera-Villalba, Sonia
    Ramirez, Julio
    Cuervo, Andrea
    Pascal, Mariona
    Yague, Jordi
    Canete, Juan D.
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] SUCCESSFUL DOSE REDUCTION OF TNF-ALPHA BLOCKING AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS WITH STABLE LOW DISEASE ACTIVITY
    Arends, S.
    van der Veer, E.
    Kamps, F. B.
    Efde, M.
    Leijsma, M. K.
    Bootsma, H.
    Brouwer, E.
    Spoorenberg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 517 - 517
  • [6] PREDICTIVE VALUE OF A MULTI-BIOMARKER DISEASE ACTIVITY SCORE FOR SUCCESSFUL DOSE REDUCTION OF TNF INHIBITORS IN RHEUMATOID ARTHRITIS: RESULTS OF THE DRESS STUDY
    Bouman, C.
    van der Maas, A.
    van Herwaarden, N.
    Segurado, O. G.
    Sasso, E. H.
    van den Haagen, F.
    den Broeder, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 973 - 974
  • [7] EFFECTIVENESS OF DOSE REDUCTION OF TNF INHIBITORS IN MAINTAINING LOW DISEASE ACTIVITY IN SEVERE ANKYLOSING SPONDYLITIS
    Fong, W.
    Holroyd, C.
    Davidson, B.
    Armstrong, R.
    Harvey, N.
    Dennison, E.
    Cooper, C.
    Edwards, C. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 285 - 286
  • [8] EFFECTIVENESS OF DOSE REDUCTION OF TNF INHIBITORS IN MAINTAINING LOW DISEASE ACTIVITY IN SEVERE PSORIATIC ARTHRITIS
    Fong, W.
    Holroyd, C.
    Davidson, B.
    Armstrong, R.
    Harvey, N.
    Dennison, E.
    Cooper, C.
    Edwards, C. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 351 - 352
  • [9] Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
    van Herwaarden, Noortje
    Bouman, Chantal A. M.
    van der Maas, Aatke
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W.
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    van den Bemt, Bart J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2260 - +
  • [10] Effectiveness of TNF inhibitors in RA patients with moderate vs high disease activity
    Keystone, E.
    Reed, G.
    Hooper, M.
    Greeberg, J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S779 - S779
12345